导航遗传景观:研究跨物种SNP阵列在鱼中的应用机会和风险
Bettina Hegedűs1,2, Zoltán Bagi1, Szilvia Kusza1
1Centre for Agricultural Genomics and Biotechnology, Faculty of Agricultural and Food Sciences and Environmental Management, University of Debrecen, Egyetem tér 1., 4032 Debrecen, Hungary.
Genes
|June 26, 2025
概括
有限的遗传数据阻碍了鱼的繁殖. 现有的高密度SNP阵列显示了在非洲和欧洲鱼中跨物种应用的潜力,尽管具有低多态性,但有助于水产养殖.
科学领域:
- 水产养殖遗传学 水产养殖遗传学
- 基因组选择 基因组选择
- 鱼类养殖 养殖鱼类
背景情况:
- 水产养殖对全球粮食安全至关重要,鱼占鱼产量的很大一部分.
- 目前的鱼育种计划受到遗传数据不足的限制,限制了它们的生产潜力.
- 高密度单核酸多态 (SNP) 阵列的开发改善了北美鱼物种的遗传洞察力.
研究的目的:
- 调查SNP芯片技术在鱼繁殖计划中的不足利用情况.
- 评估现有的SNP阵列对商业重要鱼家族 (Clariidae和Siluridae) 的跨物种适用性.
主要方法:
- 对16多个SNP数组和66个非目标物种的系统文献综述.
- 评估现有的鱼SNP阵列的潜在适应性,以确定非洲鱼 (Clarias gariepinu) 和欧洲鱼 (Silurus glanis) 的基因型.
- 分析SNP阵列性能,降低过值 (例如,小等位基因频率> 0).
主要成果:
- 现有的高密度SNP阵列 (Affymetrix Axiom 250K和690K) 显示了在非洲和欧洲鱼中跨物种应用的潜力.
- 降低过门可以使这些数组的使用,尽管最初的低多态SNP率 (~1%) 和呼叫率 (~0%).
- 在没有特定物种芯片开发的情况下,SNP阵列的交叉应用是一个可行的短期战略.
结论:
- 现有的SNP阵列可以帮助改善资源不足的鱼物种的遗传,增强水产养殖和管理.
- 开发特定物种SNP芯片仍然是最大限度地提高鱼育种中的遗传收益的长期目标.
相关概念视频
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


